REGENXBIO Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
REGENXBIO Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2023.
  • REGENXBIO Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $280M, a 32.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $280M +$69.3M +32.8% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $211M +$100M +90.6% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $111M -$32.2M -22.5% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $143M +$45.4M +46.6% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $97.5M +$46M +89.2% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $51.5M -$14.1M -21.5% Dec 31, 2018 10-K 2020-02-26
Q4 2017 $65.7M +$25.6M +63.8% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $40.1M +$28M +231% Dec 31, 2016 10-K 2018-03-06
Q4 2015 $12.1M +$9.74M +414% Dec 31, 2015 10-K 2017-03-07
Q4 2014 $2.36M Dec 31, 2014 10-K 2016-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.